Acadia Pharmaceuticals | ACAD - Pre Tax Profit

Stock Price
23.53
Daily Change
0.07 0.30%
Monthly
-14.19%
Yearly
26.85%
Q1 Forecast
24.36

Acadia Pharmaceuticals reported $44.6M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Eisai JPY 14.53B 7.87B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Incyte USD 482.31M 75.7M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Moderna USD -187M 631M Sep/2025
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Prothena USD -36.91M 44.05M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025